TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
VTRS

Viatris Inc

Healthcare · Drug Manufacturers - Specialty & Generic

17.20$ +0.5% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow VTRS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
13.1% 21.3% 18.5% 17.3% 20.5% 15.7% 10.3% 16.9% 18.2% 18.1% 15.6% 16.2%
7.0% 11.7% 13.5% 14.5% 16.5% 17.6% 18.6% 25.2% 18.6% 17.8% 18.4% 19.6%
0.9% 1.0% 0.8% 0.6% -0.6% 0.5% 0.7% 0.6% 0.7% 1.2% 1.0% 1.2%
8.0% 2.7% 2.5% 4.0% 5.9% 16.1% -6.5%
-7.1% -3.2% -8.4% -6.0% -3.4% -4.4% -5.8% -10.1% -5.7% -4.6% -2.2% -17.5%
4.2% 3.8% 3.5% 2.3% 2.2% 3.5% 5.7% 2.8% 2.7% 3.1% 2.2% 2.6%
-10.4% -16.6% -69.3% -8.2% -10.6% -4.6% -2.5% -0.7% 9.3% -5.0% 12.2% -3.0%
3.5% 0.0% 0.1% 2.2% 3.6% 3.7% 3.9% 3.9%
-0.4% -0.7% -0.2% -4.2% -3.8% -0.1% -0.1% -0.1% -0.1% -1.6% -1.7% -3.5%
49.6% -11.4% -5.5% -9.6% -3.4% -11.7% -20.2% -8.1% -25.2% 0.0%
-3.5% 6.4% 48.2% -15.9% -9.5% -10.2% -5.1% -16.8% -23.8% -14.9% -29.4% -9.0%
-0.9% 10.7% -0.8% -6.5% 0.2% 0.9% 3.0% -0.8% 3.4% -1.7% -1.7% 4.3%
8.9% 17.5% 15.0% 15.0% 18.3% 12.2% 4.6% 14.0% 15.4% 15.1% 13.4% 13.5%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?